Skip to content

Ablation for ICD Intervention Reduction in Patients With CAD

Ablation for ICD Intervention Reduction in Patients With CAD - a Prospective Randomized Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00481377
Acronym
ABLATION 4 ICD
Enrollment
200
Registered
2007-06-01
Start date
2007-05-31
Completion date
2010-05-31
Last updated
2008-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Implantable Cardioverter-Defibrillator, Ventricular Tachycardia

Keywords

Ablation, Ventricular tachycardia, coronary artery disease, Implantable cardioverter defibrillator interventions

Brief summary

The aim of this study is to assess the role of ablation in appropriate ICD interventions reduction in patients with coronary artery disease. The group will consist of 200 patients with implanted ICD and appropriate intervention in the 3 months prior to enrollment. The patients will be randomized into ablation arm and conventional treatment. Number of appropriate ICD interventions is the primary endpoint of this study. All patients will have control follow-up visits every 3 months. The follow-up will be based on ICD memory.

Interventions

PROCEDUREablation

Sponsors

National Institute of Cardiology, Warsaw, Poland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Coronary Artery Disease * ICD implanted * Appropriate ICD intervention during the 3 months prior to enrollment * Coronary angiography during the 6 months prior to enrollment * Possible revascularization * Age over 18 years * Signed informed consent

Exclusion criteria

* Age less then 18 years * Pregnancy * Active participation in other trial * Heart failure (NYHA IV) * Contraindications for ablation procedure: i.e. left ventricular thrombus, artificial aortic or mitral valve, no vascular access. * Monomorphic, incessant, ventricular tachycardia * Revascularization or other cardio-surgical procedure scheduled in the next 6 months

Design outcomes

Primary

MeasureTime frame
Number of appropriate ICD interventions

Secondary

MeasureTime frame
Overall mortality
Cardiac mortality
Hospitalization due to arrhythmia or heart failure
Quality of life

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026